Hello Traders and Readers,
I know how busy a long weekend can be with all the fun of not having to be at work. So if you didn’t have time to explore into my new pick, AXXE and their news, have no fear, I have their profile and news right here.
This play will be for Tuesday’s trading session and after the long holiday weekend I want nothing more than to kick off the trading week with a big potential winner!
AXXE is a specialty pharmaceutical and nutritional supplements company.
This stock is currently priced at $.30 and looks to be making its moves at the right times and could be ready to make a move forward in the very near future.
AXXE has potential gainer written all over it.
An epic breakout could be looming.
AXXE is ready for short-term action but its long term prospects are huge.
Here’s why:
1. AXXE has been getting actual orders for its TapouT branded supplements have been making their way via very robust distribution channels (online and offline). There leveraged distribution means that its virtually impossible for the company NOT to make sales. This one warrants your attention now.
2. AXXE is planning the launch of another vertical to its operations. Omega-3 fish oils sell like hot cakes and so the growth potential overall is going to be huge. New sales = More revenues!
AXXE has partnered up with the popular TapouT product line and they have sold out their product during their initial order together on Amazon.com. Hows that for excitement?
TapouT product line is a lifestyle brand that has been at the forefront of Mixed Martial Arts since its inception in 1997.
Mixed Martial Arts (MMA) is one of the fastest growing and most watched sports in this world!
In just a dozen years, UFC has grown into an enterprise valued at $2 billion, rivaling the market worth of the NFL’s Dallas Cowboys or Major League Baseball’s New York Yankees.
UFC content is already broadcast by more than 30 TV networks in 28 languages in 145 nations with a potential of more than 800 million viewing households!
AXXE has gained public attention across the world.
The distributor of TapouT branded muscle supplements has been in the news consistently for the last few weeks and trading interest has been relatively strong throughout.
Along the way the stock has ebbed and flowed, but all the time hinting that something big is on its way. That “something big” could very well happen in the next session; especially after news released confirmed the impending launch of a line of Omega-3 fish oil supplement.
The 12-month high for this stock is $1.04 but right now a trader can establish a short-term position for less than .30. This alone is a catalyst and I expect other high volume traders to quickly take notice of the potential that AXXE holds.
Their most recent press release is a true indication of their continued growth in North America and their stringent standards of excellence.
“Axxess Pharma Receives 2013 Canadian Excellence Award From the United States Trade and Commerce Institute (USTCI)”
Read the full release here: http://finance.yahoo.com/news/axxess-pharma-receives-2013-canadian-120000060.html
About AXXE (Axxess Pharma Inc.
(Current PPS. $.304)
Axxess Pharma Inc. is a Nevada Corporation operating through its wholly owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain -- to optimal health management through improved nutritional supplements.
About TapouT: TapouT is a lifestyle brand that has been at the forefront of Mixed Martial Arts since its inception in 1997. The label is rapidly growing into other sports and categories, offering merchandise for men, women and kids. TapouT has endorsed high-profile professional athletes who compete in sports such as basketball, football, baseball, stock car racing, and most famously, MMA. TapouT is sold in sporting goods stores, specialty retailers and online. For updates and more information, please visit TapouT.com.
MARKET OUTLOOK
The over-the-counter (OTC) pharmaceutical market includes non- prescription medicines that are sold directly to consumers through pharmacies, drugstores, convenience stores and grocery stores. Most countries follow the “two-class system” for the classification of medicines as prescription (Rx) or non-prescription (OTC). The OTC pharmaceutical market may be segmented into multiple categories such as analgesics, cold, cough and allergy, digestive remedies, traditional medicines, and vitamins and minerals.
A new report by visiongain predicts that the world market for over-the-counter (OTC) medicines will reach $80.7 billion for 2014. That revenue forecast appears in World OTC Pharmaceutical Market 2012-2022, published in June 2012.
INVESTOR HIGHLIGHTS
AXXE has already started its breakout and with the current news profile, more and more traders will pour in to capitalize.
AXXE plans to meet with large retailers at the ECRM EPPS Event - retailers including Wal-Mart and CVS!
AXXE has been dominating the headlines in recent weeks, announcing on May 1 the world-wide purchase order from the US Military for its TapouT line of pain relief and muscle growth products.
AXXE has been very powerful coming off similar situations in the recent past.
AXXE has a worldwide agreement with TapouT (Tapout is a world leading athletic lifestyle brand with revenue of $350 million.)
AXXE is a shining example of a near-perfect alert! This underpriced possibly huge hit has everything that we look for in a high-potential alert and MORE! I urge my readers to treat this alert very seriously and begin researching AXXE right away.
AXXE could be a huge opportunity so hurry and put it on your watch list!
